América Móvil, the Latin American telecom company owned by Carlos Slim, has formally pulled its €7.2 billion for the 70% of listed Dutch mobile operator KPN that it does not already own, after a Dutch foundation tied to KPN exercised its right to acquire just under a 50% voting stake in the company.www.kpn.com
Rhapsody International, a Seattle-based on-demand subscription digital music services, has raised an undisclosed amount of equity funding from Telefonica Digital, as part of a larger strategic agreement. www.rhapsody.com
River Cities Capital Funds has sold National Intergovernmental Purchasing Alliance Co., a Brentwood, Tenn.-based group purchasing organization and strategic sourcing partner for government institutions, to Provista, a subsidiary of Novation. No financial terms were disclosed.www.nationalipa.org
Sun Capital Partners has sold Gerber Childrenswear LLC, a marketer of infant and children’s apparel, to Providence Apparel Inc. No financial terms were disclosed. www.suncappart.com
TGP Investments has sold Tru-Flex Metal Hose LLC, a West Lebanon, Ind.-based maker of metal hydroformed bellows and interlock flexible hoses, to HBM Holdings, an investment vehicle for the privately-held ownership of the Mississippi Lime Co. No financial terms were disclosed.www.tgpinvestments.com
Egalet Corp., a Malvern, Penn.-based abuse-deterrent oral products for the treatment of pain and other indications, has filed for a $69 million IPO. It plans to trade on Nasdaq under ticker symbol EGLT, with Stifel and JMP Securities serving as lead underwriters. Shareholders include Atlas Ventures (30.1% pre-IPO stake), Danish Biotech (22.7%), Sunstone Capital (19.7%), Index Ventures (17.1%) and Enso Ventures (6.2%). www.egalet.com
Rice Energy, a Cannonsburg, Penn.-based gas exploration and production company sponsored byNGP Energy Capital, is planning to file for an IPO that could value the company at upwards of $2.5 billion, according to Reuters. Barclays will serve as lead underwriter. www.riceenergyllc.com
Veracyte Inc., a South San Francisco-based molecular cytology company, has set its IPO terms to 4.7 million shares being offered at between $13 and $15 per share. It would have an initial market cap of approximately $290 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol VCYT, with Morgan Stanley serving as lead underwriter. It has raised more than $50 million in VC funding from Versant Ventures (22.62% pre-IPO stake), Kleiner Perkins Caufield & Byers (22.22%), TPG Biotech Partners (22.22%), Domain Associates (19.31%) and GE Ventures. www.veracyte.com
Sign up for Dan’s daily email newsletter on deals and deal-makers: GetTermSheet.com
